203 related articles for article (PubMed ID: 29064334)
1. Melanoma treatment with intratumoral electroporation of tavokinogene telseplasmid (pIL-12, tavokinogene telseplasmid).
Canton DA; Shirley S; Wright J; Connolly R; Burkart C; Mukhopadhyay A; Twitty C; Qattan KE; Campbell JS; Le MH; Pierce RH; Gargosky S; Daud A; Algazi A
Immunotherapy; 2017 Dec; 9(16):1309-1321. PubMed ID: 29064334
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses.
Greaney SK; Algazi AP; Tsai KK; Takamura KT; Chen L; Twitty CG; Zhang L; Paciorek A; Pierce RH; Le MH; Daud AI; Fong L
Cancer Immunol Res; 2020 Feb; 8(2):246-254. PubMed ID: 31852717
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients.
Algazi A; Bhatia S; Agarwala S; Molina M; Lewis K; Faries M; Fong L; Levine LP; Franco M; Oglesby A; Ballesteros-Merino C; Bifulco CB; Fox BA; Bannavong D; Talia R; Browning E; Le MH; Pierce RH; Gargosky S; Tsai KK; Twitty C; Daud AI
Ann Oncol; 2020 Apr; 31(4):532-540. PubMed ID: 32147213
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral Plasmid IL12 Expands CD8
Telli ML; Nagata H; Wapnir I; Acharya CR; Zablotsky K; Fox BA; Bifulco CB; Jensen SM; Ballesteros-Merino C; Le MH; Pierce RH; Browning E; Hermiz R; Svenson L; Bannavong D; Jaffe K; Sell J; Foerter KM; Canton DA; Twitty CG; Osada T; Lyerly HK; Crosby EJ
Clin Cancer Res; 2021 May; 27(9):2481-2493. PubMed ID: 33593880
[TBL] [Abstract][Full Text] [Related]
5. Pembrolizumab and tavokinogene telseplasmid electroporation in metastatic melanoma.
Dollin Y; Rubin J; Carvajal RD; Rached H; Nitzkorski JR
Int J Surg Case Rep; 2020; 77():591-594. PubMed ID: 33395852
[TBL] [Abstract][Full Text] [Related]
6. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model.
Chuang TF; Lee SC; Liao KW; Hsiao YW; Lo CH; Chiang BL; Lin XZ; Tao MH; Chu RM
Int J Cancer; 2009 Aug; 125(3):698-707. PubMed ID: 19431145
[TBL] [Abstract][Full Text] [Related]
7. Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma.
Algazi AP; Twitty CG; Tsai KK; Le M; Pierce R; Browning E; Hermiz R; Canton DA; Bannavong D; Oglesby A; Francisco M; Fong L; Pittet MJ; Arlauckas SP; Garris C; Levine LP; Bifulco C; Ballesteros-Merino C; Bhatia S; Gargosky S; Andtbacka RHI; Fox BA; Rosenblum MD; Daud AI
Clin Cancer Res; 2020 Jun; 26(12):2827-2837. PubMed ID: 32376655
[TBL] [Abstract][Full Text] [Related]
8. Plasmid IL-12 electroporation in melanoma.
Cha E; Daud A
Hum Vaccin Immunother; 2012 Nov; 8(11):1734-8. PubMed ID: 23151447
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor Immunity.
Han M; Nguyen B; Lee JY; Browning E; Zhang J; Mukhopadhyay A; Gujar R; Salazar J; Hermiz R; Svenson L; Rolig AS; Redmond WL; Algazi AP; Daud AI; Canton DA; Twitty CG
Mol Cancer Res; 2022 Jun; 20(6):983-995. PubMed ID: 35302641
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma.
Bhatia S; Longino NV; Miller NJ; Kulikauskas R; Iyer JG; Ibrani D; Blom A; Byrd DR; Parvathaneni U; Twitty CG; Campbell JS; Le MH; Gargosky S; Pierce RH; Heller R; Daud AI; Nghiem P
Clin Cancer Res; 2020 Feb; 26(3):598-607. PubMed ID: 31582519
[TBL] [Abstract][Full Text] [Related]
11. Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity.
Lee JY; Nguyen B; Mukhopadhyay A; Han M; Zhang J; Gujar R; Salazar J; Hermiz R; Svenson L; Browning E; Lyerly HK; Canton DA; Fisher D; Daud A; Algazi A; Skitzki J; Twitty CG
Mol Ther Oncolytics; 2022 Jun; 25():174-188. PubMed ID: 35592387
[TBL] [Abstract][Full Text] [Related]
12. Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy.
Mukhopadhyay A; Wright J; Shirley S; Canton DA; Burkart C; Connolly RJ; Campbell JS; Pierce RH
Gene Ther; 2019 Feb; 26(1-2):1-15. PubMed ID: 30323352
[TBL] [Abstract][Full Text] [Related]
13. Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters.
Burkart C; Mukhopadhyay A; Shirley SA; Connolly RJ; Wright JH; Bahrami A; Campbell JS; Pierce RH; Canton DA
Gene Ther; 2018 Apr; 25(2):93-103. PubMed ID: 29523878
[TBL] [Abstract][Full Text] [Related]
14. Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice.
Kishida T; Asada H; Itokawa Y; Yasutomi K; Shin-Ya M; Gojo S; Cui FD; Ueda Y; Yamagishi H; Imanishi J; Mazda O
Mol Ther; 2003 Nov; 8(5):738-45. PubMed ID: 14599806
[TBL] [Abstract][Full Text] [Related]
15. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma.
Lucas ML; Heller R
DNA Cell Biol; 2003 Dec; 22(12):755-63. PubMed ID: 14683586
[TBL] [Abstract][Full Text] [Related]
16. Candidate genes associated with tumor regression mediated by intratumoral IL-12 electroporation gene therapy.
Li S; Xia X; Mellieon FM; Liu J; Steele S
Mol Ther; 2004 Mar; 9(3):347-54. PubMed ID: 15006601
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of toxicity following electrically mediated interleukin-12 gene delivery in a B16 mouse melanoma model.
Heller L; Merkler K; Westover J; Cruz Y; Coppola D; Benson K; Daud A; Heller R
Clin Cancer Res; 2006 May; 12(10):3177-83. PubMed ID: 16707618
[TBL] [Abstract][Full Text] [Related]
18. Novel Immunologic Approaches to Melanoma Treatment.
Escandell I; Martín JM; Jordá E
Actas Dermosifiliogr; 2017 Oct; 108(8):708-720. PubMed ID: 28527857
[TBL] [Abstract][Full Text] [Related]
19. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation.
Lohr F; Lo DY; Zaharoff DA; Hu K; Zhang X; Li Y; Zhao Y; Dewhirst MW; Yuan F; Li CY
Cancer Res; 2001 Apr; 61(8):3281-4. PubMed ID: 11309280
[TBL] [Abstract][Full Text] [Related]
20. Advances in the Immunobiological Therapies for Advanced Melanoma.
Pérez Gago MC; Saavedra Santa Gadea O; de la Cruz-Merino L
Actas Dermosifiliogr; 2017 Oct; 108(8):721-728. PubMed ID: 28388991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
